Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
Estimated
~$10 – $6,250
St. Jude Children's Research HospitalNCT06239272
Phase 1
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors
Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced t…
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+11 more
Estimated
~$10 – $6,250
University of FloridaNCT06625190
Phase 1
A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of HH2853 in Patients With Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors
This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II.…
FL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more
Estimated
~$10 – $8,750
Haihe Biopharma Co., Ltd.NCT04390737